Evidence map›Paper›PMID 27014456›Full record

ArticleClinical case reports2016

Local recurrence of pheochromocytoma in multiple endocrine neoplasia type 2A: a diagnostic and therapeutic challenge.

Blandine Tramunt, Alexandre Buffet, Solange Grunenwald, Delphine Vezzosi, Antoine Bennet, Eric Huyghe, Slimane Zerdoud, Philippe Caron

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Blandine TramuntService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Alexandre BuffetService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Solange GrunenwaldService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Delphine VezzosiService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Antoine BennetService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Eric HuygheService d'Urologie Andrologie et Transplantation Rénale CHU Rangueil Toulouse France.
Slimane ZerdoudService de Médecine Nucléaire Institut Universitaire du Cancer Oncopole Toulouse France.
Philippe CaronService d'Endocrinologie et Maladies Métaboliques Pôle Cardio-Vasculaire et Métabolique CHU Larrey Toulouse France.
Hôpital Rangueil · FRInstitut universitaire du cancer de Toulouse Oncopole · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a patient with multiple endocrine neoplasia type 2A (MEN2A), an inverted physiological ratio between urinary normetanephrines and metanephrines is an early marker of recurrence in epinephrine-secreting pheochromocytoma, and 131I MIBG treatment appears to be a useful therapeutic option in order to avoid multiple invasive surgical procedures in pheochromocytomatosis.

Indexed as

131I‐MIBG therapyMEN2Apheochromocytomarecurrencesurgery

Identifiers

PMID27014456
PMCPMC4771851
OpenAlexW2259349143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.